{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:26Z","timestamp":1787729486895,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.atherosclerosis.2015.11.032","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T07:49:44Z","timestamp":1448956184000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging"],"prefix":"10.1016","volume":"245","author":[{"given":"Kevin D.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Hippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5510","authenticated-orcid":false,"given":"Huijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moni B.","family":"Neradilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-9971","authenticated-orcid":false,"given":"Jeffrey L.","family":"Probstfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Isquith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gador","family":"Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayak L.","family":"Polissar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib1","first-page":"657","volume":"92","author":"Falk","year":"1995","journal-title":"Coron. Plaque Disrupt."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11883-014-0401-9","article-title":"Pathophysiology of acute coronary syndrome","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0021-9150(91)90235-U","article-title":"Atherosclerotic plaque caps are locally weakened when macrophages density is increased","volume":"87","author":"Lendon","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content","volume":"69","author":"Davies","year":"1993","journal-title":"Br. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib6","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/CIRCULATIONAHA.105.578955","article-title":"Neovascularization in human atherosclerosis","volume":"113","author":"Moreno","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI116670","article-title":"Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis","volume":"92","author":"O'Brien","year":"1993","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.93.4.672","article-title":"Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content","volume":"93","author":"O'Brien","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.CIR.0000048145.52309.31","article-title":"Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque","volume":"107","author":"Kerwin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiol.2412051336","article-title":"Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study","volume":"241","author":"Kerwin","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.12120499","article-title":"Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation","volume":"266","author":"Gaens","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib13","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in\u00a0vivo and in\u00a0vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib17","first-page":"415","article-title":"Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering","volume":"105","author":"Wilson","year":"2002"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2010.11.008","article-title":"Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels","volume":"214","author":"Bot","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jcmg.2011.11.025","article-title":"Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin","volume":"5","author":"Vucic","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/heartjnl-2012-302775","article-title":"Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: contrast-enhanced ultrasound imaging and intravascular ultrasound study","volume":"99","author":"Tian","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1148\/radiol.2482071114","article-title":"Carotid plaque morphology and composition: initial comparison between 1.5- and 3.0-T magnetic field strengths","volume":"248","author":"Underhill","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12968-014-0051-7","article-title":"Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study","volume":"16","author":"Chen","year":"2014","journal-title":"J.\u00a0Cardiovasc Magn. Reson"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib24","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.amjcard.2014.08.001","article-title":"Clinical factors associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with established vascular disease (from the AIM-HIGH Study)","volume":"114","author":"Zhao","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/rmr.0b013e3181598d9d","article-title":"Magnetic resonance imaging of carotid atherosclerosis: plaque analysis","volume":"18","author":"Kerwin","year":"2007","journal-title":"Top. Magn. Reson Imaging"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mrm.21532","article-title":"MR imaging of adventitial vasa vasorum in carotid atherosclerosis","volume":"59","author":"Kerwin","year":"2008","journal-title":"Magn. Reson Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib27","unstructured":"O'Brien, K, Hippe, D, Chen, H, et\u00a0al., Summary of Clinical and Laboratory Data from those on Statin Therapy at Enrollment in the AIM-HIGH Trial, Submitted to the journal - Data in Brief."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM198401193100307","article-title":"Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis","volume":"310","author":"Barger","year":"1984","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cardiores.2007.06.020","article-title":"The dynamic vasa vasorum","volume":"75","author":"Ritman","year":"2007","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1358863X11402249","article-title":"Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis","volume":"16","author":"Purushothaman","year":"2011","journal-title":"Vasc. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib32","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncpcardio1086","article-title":"Rapid regression of atherosclerosis: insights from the clinical and experimental literature","volume":"5","author":"Williams","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06497.x","article-title":"Plaque neovascularization: defense mechanisms, betrayal, or a war in progress","volume":"1254","author":"Moreno","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1194\/jlr.M012526","article-title":"Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study","volume":"52","author":"Lamon-Fava","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib39","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng.314","article-title":"Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease","volume":"41","author":"Tr\u00e9gou\u00ebt","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.ATV.9.5.579","article-title":"Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients","volume":"9","author":"Rath","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/clinchem\/41.2.246","article-title":"Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)","volume":"41","author":"Marcovina","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib44","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1194\/jlr.P021113","article-title":"Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)","volume":"53","author":"Deshmukh","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib45","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","article-title":"Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL\/High Triglyceride and Impact on Global Health Outcomes)","volume":"62","author":"Albers","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib46","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2013.07.023","article-title":"Relationship of lipoproteins to cardiovascular events: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL\/High Triglycerides and Impact on Global Health Outcomes)","volume":"62","author":"Guyton","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1148\/radiol.11101264","article-title":"Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum \u2013 evaluation by using dynamic contrast-enhanced MR imaging","volume":"260","author":"Dong","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10554-014-0532-7","article-title":"Carotid magnetic resonance imaging for monitoring atherosclerotic plaque progression: a multicenter reproducibility study","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-15-42","article-title":"SHILO, a novel dual imaging approach for simultaneous HI-\/Low temporal (Low-\/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries","volume":"15","author":"Calcagno","year":"2013","journal-title":"J.\u00a0Cardiovasc Magn. Reson"},{"key":"10.1016\/j.atherosclerosis.2015.11.032_bib50","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mrm.24415","article-title":"Progression of experimental lesions of atherosclerosis: assessment by kinetic modeling of black-blood dynamic contrast-enhanced MRI","volume":"69","author":"Chen","year":"2013","journal-title":"Magn. Reson Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015302288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T03:30:58Z","timestamp":1599881458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015302288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":50,"alternative-id":["S0021915015302288"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}